Skip to content

Clinical trials

Critical Illness trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Critical Illness Country / region: China Clear all

109 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20111
20122
20134
20143
20155
20167
20174
20187
20195
20204
20215
202211
202312
202413
20259
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status39
Completed39
Recruiting17
Not yet recruiting8
Withdrawn3
Suspended1
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Zhongshan Hospital9
Peking Union Medical College Hospital7
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology7
Second Affiliated Hospital, Zhejiang University, School of Medicine6
Children's Hospital of Fudan University5
Chinese Medical Association4
Peking University Third Hospital4
Ruijin Hospital4
Capital Medical University3
First Affiliated Hospital of Wannan Medical College3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Critical Illness109
Sepsis12
Acute Kidney Injury11
Respiratory Insufficiency10
Multiple Organ Failure4
Respiratory Distress Syndrome4
Shock4
Shock, Septic4
Hyperglycemia3
Infections3

Trials

Showing 1 to 25 of 109. Each trial links to its page on Pharma Observatory.

9 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.